Cite
HARVARD Citation
Beran, D. et al. (2023). Teplizumab approval for type 1 diabetes in the USA. Lancet. 11 (2), pp. 78-80. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Beran, D. et al. (2023). Teplizumab approval for type 1 diabetes in the USA. Lancet. 11 (2), pp. 78-80. [Online].